Thursday, March 23, 2023
  • Login
Euro Times
No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
Euro Times
No Result
View All Result

Dividend Champion, Contender, And Challenger Highlights: Week Of October 2

by Euro Times
October 2, 2022
in Business
Reading Time: 1 min read
A A
0
Home Business
Share on FacebookShare on Twitter


This article was written by

Maximize your income with the world’s highest-quality dividend investments

I am the curator of the Dividend Champions list, a monthly publication of companies with a history of consistently increasing their dividends. My primary investing focus is in deep value and dividend paying stocks, but I am constantly exploring alternative strategies. I have a Ph.D in Chemistry from Rice University and have earned the CFA Institute Investment Foundations certificate. I am a contributor to The Dividend Kings marketplace service.

Disclosure: I/we have a beneficial long position in the shares of BMY, CMCSA, CSCO, HBNC, LMT, MRK, SYY, VZ either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.



Source link

Tags: ChallengerchampioncontenderDividendhighlightsOctoberweek
Previous Post

German delegation arrives in Taiwan — RT World News

Next Post

Is BRRRR Investing About to Get Even Better?

Related Posts

Craftsman Automation – DR Axion Good Asset At Reasonable Price: Motilal Oswal

by Motilal Oswal Financial Services
March 23, 2023
0

BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset...

Clalit teams with Harvard on ‘imitating’ clinical trials

by Gali Weinreb
March 23, 2023
0

Gali Weinreb Big data technologies are changing the way clinical trials are conducted and transforming the way data about...

US Federal Reserve raises policy rate by 25 bps; 9th straight hike

by Euro Times
March 22, 2023
0

US Federal Reserve raised the policy rate by 25 basis points. The Federal Open...

India, the largest arms importer

by Euro Times
March 23, 2023
0

India’s arms imports continue to be the highest globally with 45 per cent of its shipments coming from Russia. The...

SoFi to boost FDIC insurance coverage to $2M for checking, savings members (NASDAQ:SOFI)

by Euro Times
March 22, 2023
0

Justin Sullivan/Getty Images News SoFi Technologies (NASDAQ:SOFI) will offer members with checking or savings accounts access up to $2M of...

Stellantis to invest €130M in German assembly plant By Investing.com

by Investing.com
March 22, 2023
0

© Reuters. Stellantis (STLA) to invest €130M in German assembly plant By Michael Elkins Stellantis (NYSE:) announced Wednesday that the American...

Next Post

Is BRRRR Investing About to Get Even Better?

Interview – Cas Mudde

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Arcus Biosciences: Anti-TIGIT Therapy On Track With ARC-7 Results (NYSE:RCUS)

March 23, 2023

Craftsman Automation – DR Axion Good Asset At Reasonable Price: Motilal Oswal

March 23, 2023

Increasing Supply At Key Resistance Puts Avalanche Coin On 15% Downside Risk

March 23, 2023

Top 40 High-Yield Blue-Chip U.K. Stocks: Spring 2023

March 23, 2023

Big jump in migrants crossing Panama’s dangerous Darien Gap

March 23, 2023

The Banking Crisis for Dummies And why it means more inflation ahead. – Investment Watch

March 23, 2023
Euro Times

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Finance
  • Health
  • Investing
  • Markets
  • Politics
  • Stock Market
  • Technology
  • Uncategorized
  • World

LATEST UPDATES

Arcus Biosciences: Anti-TIGIT Therapy On Track With ARC-7 Results (NYSE:RCUS)

Craftsman Automation – DR Axion Good Asset At Reasonable Price: Motilal Oswal

  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In